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ABSTRACT
￿
The morphological transformation of Trypanosoma cruzi amastigotes was studied
in both mammalian cells and an extracellular differentiation system. Inhibitors of ADP-ribosyl
transferase were found to block differentiation in both cases, without affecting proliferation.
The inhibitory effect was reversible and was not observed with chemical analogues that do
not inhibit ADP-ribosyl transferase . As inhibitors of ADP-ribosyl transferase have recently been
shown to block the differentiation of several cell types from vertebrates (Farzaneh, F., R. Zalin,
D . Brill, and S. Shall, 1982, Nature (Lond.), 300:362-366; Johnstone, A. P., and G . T. Williams,
1982, Nature (Lond.), 300:368-370), our results suggest that the enzyme is of general impor-
tance in eucaryotic differentiation both in multicellular and unicellular organisms. In addition,
since the compounds can block T. cruzi differentiation inside mammalian cells, these results
suggest that it may be possible to exploit such inhibition in a new and potentially powerful
approach to the chemotherapy of several important parasitic diseases.
Protozoan differentiation is a cyclic process that appears
different in many ways from the differentiation ofthe cellsof
higher eucaryotes. The full molecular basis of differentiation
has yet to be firmly established for any eucaryotic cell. How-
ever, several reports have suggested that nuclear ADP-ribosyl
transferase (ADPRT),` an enzyme found in the nuclei ofboth
higher eucaryotic cells (1-3) and protozoa (4, 5), may be
involved (6-9). Most recently, a requirement for ADPRT
activity has been demonstrated in the differentiation ofthree
cell types (10-12). However, before the present investigation
a requirement for ADPRT activity had been shown only in
cells from higher animals. The data presented here show that
inhibitors of ADPRT also block the transition between differ-
ent morphological forms of the protozoan Trypanosoma
cruzi, indicating that the enzyme is widely employed in cell
differentiation in eucaryotes.
T. cruzi differentiates between three morphological stages
during its life cycle (13, 14). Two stages, the epimastigote and
the trypomastigote, possess flagella. The amastigote stage,
which is nonmotile, normally proliferates inside mammalian
cells (for example, see references 15, 16), but can also be
grown extracellularly in a number of systems (references 17-
19). In the experiments described here, amastigotes derived
'Abbreviation used in this paper:
￿
ADPRT . ADP-ribosyl transferace.
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from extracellular culture were induced to differentiate extra-
cellularly. If amastigotes were grown with murine S2 cells at
37°C, purified, and transferred to Warren's medium (20) at
27°C, 30-50% differentiated and produced a rudimentary
flagellum after 3 to 4 d. Subsequently both epimastigotes and
trypomastigotes were formed. Amastigote differentiation in
this system was also blocked by compounds which inhibit
ADPRT.
MATERIALS AND METHODS
Chemicals:
￿
3-Aminobenzamide was obtained from the Sigma Chemi-
cal Co. (London, UK); 3-methoxybenzamide and 3-aminobenzoic acid were
obtained from Aldrich ChemicalCo. (Gillingham, UK). 5-Methylnicotinamide
was a gift from Professor S. Shall (University ofSussex, Brighton, UK).
T . CRUZ[:
￿
This parasite was handled as is appropriate for this type of
human pathogen. T. cruzi Y strain was maintained in continuous-flow culture
at 4 x 107 parasites/ml. Wel Tryp 2All, a Y strain clone, was co-cultivated
with the adherent mouse muscle tumour line S2, in Dulbecco's modification
ofEagle's minimal essential medium (DME) containing 160 /g/ml gentarnycin
(Roussel, Ltd., London, England) and 10% fetal calf serum (Gibco Europe
Ltd., Paisley, Scotland) to produce amastigotes (19).
Extracellular Differentiation of
T. ciuzi Amastigotes
Thenonmotile amastigotes were harvested from the supernatants ofcultures
containing S2 cell monolayers. These supernatants usually contained a small
79number of the mammalian cells thatwere removed by centrifugation for 1 min
at 600 g. The amastigotes in the culture medium were then pelleted by
centrifuging for 15 min at 600 g. The supernatant medium was removed and
the amastigotes were resuspended at 5 x 103 cells/ml in Warren's medium (20)
consisting of brain-heart infusion (Oxoid Ltd., Basingstoke, England) contain-
ing 10% fetal calf serum and 20 mg/liter haemin (BDH, Poole, England), pH
7.4. The cultures were then transferred to 27°C and samples were removed at
intervals under sterile conditions for examination using a phase-contrast light
microscope. Differentiatingparasites were not fixedbefore examinationbecause
the development of the rudimentary but active flagella that occurred after a
few days incubation was much more easily detected using live parasites. The
concentration of parasites possessing these whip-like flagella, together with the
concentrations ofmature epimastigotes and trypomastigotes, were determined
using a haemocytometer.
Quadruplicate 2-ml cultures in closed 10 ml screw-top glass bottles were
normally used for the incubations, but the rate ofparasite differentiation was
not substantially affected by varyingthe culture volume between 500 jut and 10
ml. Similarly, the rate of differentiation (percent of total parasites possessing
flagella at day 5) was largely independent of initial parasite concentration
between 5 x 103 cells/ml and 5 x 106 cells/ml.
Theeffects ofchemical inhibitorsonparasitedifferentiationwere determined
by incubating the amastigotecultures with the inhibitor for 18 h at 37°Cbefore
the transfer to Warren's medium containing inhibitor at 27°C. Pre-incubation,
to allow complete penetration ofthe inhibitors into the cells, was performed at
5 x 103 amastigotes/ml in Dulbecco's modified Eagle's medium (DME) with
10% fetal calfserum and 160 Ag/ml gentamycin.
INTRACELLULAR DIFFERENTIATION OF T . CRUZI :
￿
S2 cells to be
infected with T. cruzi were grown in DME with 10% fetal calf serum and 160
ag/ml gentamycin in plastic 24 well tissue culture plates (Costar 3524, L. H.
Engineering, Stoke Poges, UK). S2 cells were dispensed into wells at a density
of 1 x 103 cells/ml. After 24 h, each S2 cell culture was infected with 1 x 103
Y strain trypomastigotes derived from previously infected S2 cell cultures. After
24 h incubation at 37°C all cultures were washed 5x with phosphate-buffered
saline to remove extracellular trypomastigotes and incubated in 1 ml DME
with fetal calfserum and gentamycin. Cultureswere re-fed after a furtherperiod
of 24 h. In experimental cultures, potential inhibitors were present in all
medium added after the removal oftrypomastigotes. The emergence oftrypo-
mastigotes was monitored using an inverted microscope.
RESULTS AND DISCUSSION
After 3 d of incubation at 27°C, an increasing number of
amastigotes began to develop active whip-like flagella (Fig. 1).
About 1 d later, mature T. cruzi trypomastigotes and epimas-
tigotes began to appear. At progressively later times, the
numbers of mature epimastigotes and trypomastigotes in-
FIGURE 1
￿
Differentiation of T.
cruzi amastigotes at 27°C. Y
strain clone Wel Tryp 2All
amastigotes were obtained
from cultures of T. cruzi and
S2 mouse muscle tumor cells
(19). Contaminating S2 cells
were removed by centrifuga-
tion for 1 min at 600 g and the
amastigotes incubated for 18
h at 37°C in DME with 10%
fetal calf serum and 160 Wg/ml
gentamycin at 5 x 105 cells/
ml. The amastigotes were then
centrifuged for 15 min at 600 g and resuspended at 5 x 105 cells/
ml in Warren's medium (20) containing 10% fetal calf serum and
incubated at 27°C. Samples were removed under sterile conditions
at intervals and the total concentration of parasites which had
differentiated was determined by phase-contrast light microscopy
using a haemocytometer (0). Parasites with rudimentary but active
flagella (0) first appeared, followed by epimastigotes (") and try-
pomastigotes (*). The means and standard errors (except where
encompassed by the symbols) of four replicate cultures are shown
in each case. Zero time is the time of transfer of amastigotes to
Warren's medium (20) at 27°C.
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creased and the numbers of parasites with only rudimentary
flagella reached a plateau and later declined (Fig. 1). After
prolonged incubation and subculturing, the epimastigote stage
predominated, presumably because ofthe proliferation of this
form of the parasite at 27°C. The flagellated forms of the
parasite together made up 30-50% of the total number after
5 d of incubation.
The time course of appearance of the flagellated stages of
the parasite suggested that both the epimastigotes and the
trypomastigotes were derived from parasites with whip-like
flagella that were the first to appear. However, since trypo-
mastigotes and epimastigotes began to appear at approxi-
mately the same time, there was no indication that trypomas-
tigotes were derived from mature epimastigotes (Fig. 1).
The differentiation of amastigotes grown in extracellular
culture reported here has proved, over a period of 2 yr, to be
a convenient and reliable experimental system with which to
investigate the molecular processes involved in protozoan
differentiation.
3-Methoxybenzamide and 5-methylnicotinamide are pow-
erful inhibitors of ADPRT (21, 22) and strongly inhibit the
differentiation ofchick myoblasts (9, 10) and human periph-
eral blood lymphocytes (12). Both these compounds blocked
the differentiation of amastigotes to the flagellated stages (Fig.
2, A and B). It is important to note that these inhibitors did
not affect the differentiation-independent proliferation of T.
c
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FIGURE 2
￿
Effect of ADPRT inhibitors on differentiation and prolif-
eration of T. cruzi. (A and B) Effect on differentiation. Amastigotes
were obtained as described in the legend to Fig. 1, and were
incubated for 18 h at 37°C in DME with 10% fetal calf serum and
inhibitor (except in controls). The amastigotes were centrifuged and
resuspended at the same cell density, 5 x 105 cells/ml, in Warren's
medium (20) with 10% fetal calf serum at 27°C with inhibitor
(except in controls) (0 hours) . Total numbers of flagellated forms
were counted daily using a haemocytometer. (C and D) Effect on
proliferation. Y strain epimastigote forms were grown at 27°C in
Warren's medium (20) with 10% newborn calf serum. Parasite
numbers were measured after fixation using a model ZB Coulter
Counter. (/) 2 mM 3-Methoxybenzamide (A and C) or 5 mM 5-
methylnicotinamide (8 and D) continuously present. (A) 2 mM 3-
Methoxybenzamide (A) or 5 mM 5-methylnicotinamide (8) present
up to 24 h. (0) No inhibitor. The mean and standard error (except
where contained within the symbol) of four cultures is shown for
each time point.cruzi epimastigotes (Fig. 2, C and D), and that inhibition of
differentiation was abolished by removal of the inhibitors
after 24 h (Fig. 2, A and B) indicating that the parasites
remained viable. The effect ofADPRT inhibitors on myoblast
differentiation was also reversible (9, 10). Other ADPRT
inhibitors, 3-aminobenzamide (21), benzamide (23), nicotin-
amide (22), and theophylline (24) also inhibited T. cruzi
differentiation (25), which indicates that specific inhibition of
differentiation is a general property of these compounds.
Nicotinic acid, which does not inhibit ADPRT, had no effect.
The ADPRT inhibitors inhibited T. cruzi differentiation at
concentrations that were the same as, or slightly lower than,
those used for myoblasts (9, 10), lymphocytes (12) and hepa-
tocytes (11).
The presence of 3-methoxybenzamide or 5-methylnicotin-
amide for only the first 24 h of culture did significantly delay
the appearance of flagellated parasites (Fig. 2, A and B),
indicating that an early stage of the differentiation process
was blocked. To establish more precisely the stage at which
the protozoa were susceptible to inhibition, 5-methylnicotin-
amide was added to differentiating amastigotes at different
times before or after transfer to Warren's medium at 27°C
(Fig. 3). It is clear that differentiation was strongly inhibited
when 5-methylnicotinamide was added before or within a few
hours of transfer, but was affected only marginally if the
inhibitor was added after20 h. Since the flagellated formsdid
not appear in significant numbers until -90 h after transfer,
5-methylnicotinamide appears to act very early in the transi-
tion between stages. This is markedly similar to its effect on
the mitogen-stimulated activation ofhuman peripheral blood
lymphocytes (12).
The process of cell differentiation is of crucial importance
for T. cruzi. In its mammalian hosts, the protozoan parasite
exists in two inter-dependent forms. The trypomastigote stage
infects many cell types but does not proliferate and it differ-
entiates to the amastigote soon after penetration. The amas-
tigotes multiply intracellularly and differentiate to trypomas-
tigotes before rupture ofthe host-cell to continue the infection.
This intracellular transition from amastigote to trypomasti-
gote form is again blocked by ADPRT inhibitors. 3-Amino-
benzamide substantially delayed the appearanceoftrypomas-
tigotes, but the non-inhibitory analogue, 3-aminobenzoic acid
had no effect (Fig. 4A). The more powerful inhibitors, 5-
FIGURE 3
￿
Effect of time of addition of 5-methylnicotinamide on T.
cruzi differentiation . Amastigotes were prepared as described for
Fig. 1 and transferred to Warren's medium at 27°C at time zero. 5-
Methylnicotinamide was added, to a final concentration of 5 mM,
to separate cultures at the times indicated and the numbers of
flagellated cells counted with a haemocytometer at 96 h. This was
expressedas a percentage of the flagellated cells in control cultures
without 5-methylnicotinamide. The mean and standard error (ex-
cept where containedwithin the symbols) of four cultures is shown
for each time point.
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FIGURE 4
￿
Inhibition of the intracellular infection cycle of T. cruzi.
S2 cells were plated into 24 well tissue culture plates (Costar, U.K.)
in DMEwith 10% fetal calf serum at adensity of 1 x 105cells/ml (1
ml/well).After48 h, 2 x 105 Y strain trypomastigotes(from T. cruzil
S2 cell cultures) in complete medium with or withoutinhibitorwere
added to each well. After a further day, all cultures were washed
five timeswith phosphate-buffered saline and fedwith 1 ml of DME
with 10% fetal calf serum with or without inhibitor. In C, 500 pl of
each culture was replaced with appropriate fresh medium at 4 d
and at daily intervals afterwards to prolongthe culture period. The
appearance of trypomastigotes in the supernatant was monitored
by using an inverted microscope to examine each culture without
removing any of the medium. The average number of trypomasti-
gotes per microscope field wasdirectly proportional to the number
per milliliter. The concentration of trypomastigotes was expressed
as a percentage of the maximum observed in control cultures (at
day 5 for experiments A and B, and at day 6 for experiment C) to
allow experiments A, B, and C to be compared. The mean and
standard error (except where contained within the symbol) of four
cultures is shown at each time point. (4) 5 mM 3-aminobenzoic
acid (Aldrich) present continuously. (/)A: 5 mM 3-aminobenzamide
present continuously. (/) B: 5 mM 5-methylnicotinamide present
continuously. (/) C: 2 mM 3-methoxybenzamide present from day
1 onwards. (A) 2 mM 3-methoxybenzamide present day 1-3. (0)
No inhibitor.
methylnicotinamide and 3-methoxybenzamide, inhibited the
appearance of trypomastigotes more strongly (Fig. 4, B and
C). However, this inhibition could again be reversed simply
by removal of the inhibitor (Fig. 4 C). The intracellular pro-
liferation of amastigotes was unaffected and in infected cells
treated with 3-methoxybenzamide, >95% of the parasites
were present as amastigotes, illustrating that differentiation
rather than release was blocked.
Several different inhibitors of ADPRT therefore block the
morphological differentiation of T. cruzi without blocking
proliferation in both of the experimental systems studied. The
absence of an effect on proliferation illustrates the specificity
of action of the inhibitors at the concentrations used. Chem-
ical analogues that do not affect ADPRT had no effect. This
suggests that ADPRT activity is required for the cell differ-
entiation of this protozoan cell, although it is not needed for
growth or division. This interpretation is considerably
strengthened by reports that ADPRT activity is required for
the differentiation of chick myoblasts (9, 10) and human
lymphocytes (12), and also for the induction of fetal enzymes
in cultured hepatocytes (11). These observations together
suggest that ADPRT may be involved in the activation of
cell-type-specific genes by a general mechanism employed by
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8 1higher animals, by protozoa and also quite possibly, by many
other eucaryotes. This mechanism may well involve impor-
tant structural changes in the DNA of the differentiating cell
(10, 12, 27).
These observations may have significant practical implica-
tions. Several of the protozoa that cause important diseases
in man and animals, notably T. cruzi and the malaria parasite,
Plasmodium, are heavily dependent on morphological differ-
entiation during their infection cycles. It should therefore be
possible to use inhibitors of parasite differentiation in the
chemotherapy of such infections. These could be more pow-
erful inhibitors of ADPRT developed from those already in
use, or drugs that interfere with any other process specifically
involved. The mechanism of action of such compounds is
fundamentally different from the conventional cytotoxic and
cytostatic drugs in current use. Since inhibitors of ADPRT
also block the differentiation of mammalian cells, it is likely
that such chemotherapy would be most effective when com-
pounds have been developed that are specific for parasite
ADPRTs, and when ADPRT inhibitors are used in conjunc-
tion with conventional anti-parasitic drugs. It has recently
been reported that even currently available ADPRT inhibi-
tors, given without other drugs, do provide significant protec-
tion to mice experimentally infected with Plasmodium yoelii
(26).
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